Top Three Benefits of Locus-Specific Patient Databases for Rare Disease
In a recent webinar, Genomenon’s chief scientific officer Dr. Mark Kiel was joined by Dr. Gus Khursigara, VP of Medical Affairs and Clinical Strategy at Inozyme Pharma. This blog explores three key benefits of locus-specific patient databases (or Patient Landscapes), and how they are helping Inozyme better understand and target rare diseases.
Latest Updates to Mastermind: Search and Filter Interface
Updates to Mastermind: Search and Filter Interface Revisions – More Compact, Faster, and More Informative These are some of the latest improvements we’ve made to the search interface in the Mastermind Genomic Search Engine. The updates are especially useful for users searching with smaller screen devices such as notebook computers or tablets.
Genomenon is 2020 Company of the Year in Global Clinical Genomics Interpretation
Genomenon was named the 2020 Global Company of the Year in Clinical Genomics Interpretation by Frost & Sullivan today. The distinguished award highlights the superiority of Mastermind as a pioneering and first-in-class genomic database and leading research tool accelerating precision medicine. Below is the report in its entirety.
Google Scholar vs. Mastermind: Variant Interpretation Comparison
In the test described below, the Mastermind Genomic Search Engine was found to have several meaningful advantages over Google Scholar as a tool for searching genomic evidence, reducing the amount of time required to curate a variant and resulting in fewer missed articles containing evidence for the variant. Users who searched Mastermind as part of …